We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia (Lab2Life)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00917280
First Posted: June 10, 2009
Last Update Posted: June 3, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Erin Foster, Washington University School of Medicine
June 8, 2009
June 10, 2009
June 3, 2015
December 2008
July 2014   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00917280 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia
Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in PD Without Dementia
The overall purpose of this research is to learn how Parkinson's disease affects thinking and memory in everyday life. Participation will involve thinking tests, questionnaires and interviews about thinking and activities in everyday life.
The overall purpose of this research is to learn how Parkinson's disease affects thinking and memory in everyday life. Participation will involve thinking tests, questionnaires and interviews about thinking and activities in everyday life.
Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Controls:

Recruited from community, VFH.

Parkinson's Disease
Not Provided
  • Parkinson's Disease
    Parkinson Disease participants without dementia
  • Control
    Non-PD participants, matched for age, education and gender.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
174
July 2014
July 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria PD participants:

  • WUSM Movement Disorders Clinic patients
  • males or females between 40 and 70
  • meet criteria for idiopathic typical PD
  • classified at Hoehn & Yahr12 stage I, II, or III
  • are currently treated with levodopa/carbidopa

Inclusion Criteria Control:

  • The groups will be matched for age, education and gender
  • No Parkinson Disease

Exclusion Criteria PD participants and Control:

  • suspected dementia
  • treatment with certain dopaminergic, anticholinergic or benzodiazepine medications
  • other neurological problems
  • brain surgery
  • history or current psychotic disorder
  • any condition which would interfere with testing
  • control only: a biological family history of PD and being a caregiver or spouse of someone who has PD
Sexes Eligible for Study: All
40 Years to 70 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00917280
#E07-117
No
Not Provided
Not Provided
Erin Foster, Washington University School of Medicine
Washington University School of Medicine
Not Provided
Principal Investigator: Erin Foster Washington University School of Medicine
Washington University School of Medicine
June 2015